Sotagliflozin attenuates liver-associated disorders in cystic fibrosis rabbits is a research paper published in JCI Insight (2024). On theSindex it has a DataRank of 0.345. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: HL133162
National Institutes of Health
Grant: DK090313
National Institutes of Health
Grant: DK126908
Cystic Fibrosis Foundation
Grant: XU19XX0
National Institutes of Health
Grant: DK134361
National Institutes of Health
Grant: 5R01DK134361-02
Targeting SGLTs for liver disease in a rabbit model of cystic fibrosis
National Institutes of Health
Grant: 5R01DK090313-12
A novel CREBH-derived hepatokine regulates triglyceride metabolism
National Institutes of Health
Grant: 5R01HL133162-04
Rabbit model for cystic fibrosis
National Institutes of Health
Grant: 5R01DK126908-04
Regulation of Rhythmic m6A RNA Modification by ER‐associated Degradation
NHLBI NIH HHS
Grant: R01 HL147527
NHLBI NIH HHS
Grant: R01 HL159900
NIDDK NIH HHS
Grant: R01 DK090313
NHLBI NIH HHS
Grant: R01 HL166203
NIDDK NIH HHS
Grant: R01 DK134361
NIDDK NIH HHS
Grant: R01 DK126908
NIDDK NIH HHS
Grant: R42 DK141338
NHLBI NIH HHS
Grant: R01 HL133162
NHLBI NIH HHS
Grant: R01 HL165688
FWCI
2.50
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals